The Ministry of Health has published Ebola DRC - Evolution of the response to the Ebola epidemic in North Kivu and Ituri on Monday February 4 2019. Excerpt from the Google translation:
EPIDEMIOLOGICAL SITUATION IN THE PROVINCES OF NORTH KIVU AND ITURI
Monday, February 4, 2019
The epidemiological situation of the Ebola Virus Disease dated February 3, 2019:
• Since the beginning of the epidemic, the cumulative number of cases is 785, of which 731 are confirmed and 54 are probable. In total, there were 484 deaths (430 confirmed and 54 probable) and 265 people healed.
• 165 suspected cases under investigation.
• 11 new confirmed cases, including 4 in Katwa, 3 in Kyondo, 2 in Butembo, 1 in Kalunguta, and 1 in Vuhovi.
• 3 new deaths of confirmed cases:
º 2 community deaths, including 1 in Kyondo and 1 in Vuhovi
º 1 death at the CTE of Butembo.
• 1 person healed out of CTE Katwa.
/! \ The data presented in this table is subject to further changes after thorough investigation and after redistribution of cases and deaths in their health areas.
News of the response
Vaccination
• Since vaccination began on August 8, 2018, 73,309 people have been vaccinated , including 20,473 in Beni, 17,993 in Katwa, 8,099 in Butembo, 6,008 in Mabalako, 2,686 in Kalunguta, 2,200 in Komanda, 1,991 in Goma, 1,821 in Oicha, 1,663 at Mandima, 1,157 at Karisimbi, 1053 at Kayina, 953 at Vuhovi, 892 at Kyondo, 820 at Masereka, 764 at Bunia, 700 at Lubero, 649 at Mutwanga, 590 at Rutshuru, 567 at Biena, 527 at Nyankunde, 510 at Musienene, 355 in Tchomia, 232 in Mangurujipa, 204 in Alimbongo, 167 in Kirotshe, 125 in Nyiragongo, 97 in Watsa (Haut-Uélé) and 13 in Kisangani.
• The only vaccine to be used in this outbreak is the rVSV-ZEBOV vaccine, manufactured by the pharmaceutical group Merck, following approval by the Ethics Committee in its decision of 19 May 2018.
